Signaturefd LLC Trims Stock Position in Amdocs Limited (NASDAQ:DOX)

Signaturefd LLC cut its position in shares of Amdocs Limited (NASDAQ:DOX) by 17.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,031 shares of the technology company’s stock after selling 848 shares during the period. Signaturefd LLC’s holdings in Amdocs were worth $354,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Financiere des Professionnels Fonds d investissement inc. raised its stake in Amdocs by 1.3% during the fourth quarter. Financiere des Professionnels Fonds d investissement inc. now owns 9,790 shares of the technology company’s stock worth $860,000 after purchasing an additional 130 shares during the period. First Eagle Investment Management LLC raised its stake in shares of Amdocs by 6.3% in the 3rd quarter. First Eagle Investment Management LLC now owns 2,448 shares of the technology company’s stock valued at $207,000 after acquiring an additional 145 shares during the period. CI Investments Inc. raised its stake in shares of Amdocs by 0.7% in the 3rd quarter. CI Investments Inc. now owns 21,000 shares of the technology company’s stock valued at $1,774,000 after acquiring an additional 152 shares during the period. Balentine LLC raised its stake in shares of Amdocs by 5.3% in the 3rd quarter. Balentine LLC now owns 3,050 shares of the technology company’s stock valued at $258,000 after acquiring an additional 153 shares during the period. Finally, Wahed Invest LLC raised its stake in shares of Amdocs by 9.8% in the 3rd quarter. Wahed Invest LLC now owns 1,870 shares of the technology company’s stock valued at $158,000 after acquiring an additional 167 shares during the period. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs Trading Down 1.3 %

NASDAQ DOX opened at $85.64 on Friday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.21. Amdocs Limited has a 52 week low of $78.38 and a 52 week high of $99.75. The stock has a market capitalization of $10.07 billion, a PE ratio of 18.34, a price-to-earnings-growth ratio of 1.41 and a beta of 0.69. The firm has a 50 day moving average of $89.75 and a two-hundred day moving average of $87.31.

Amdocs (NASDAQ:DOX) last posted its quarterly earnings results on Tuesday, February 6th. The technology company reported $1.56 EPS for the quarter, topping the consensus estimate of $1.40 by $0.16. Amdocs had a net margin of 11.30% and a return on equity of 17.79%. The company had revenue of $1.25 billion during the quarter, compared to analysts’ expectations of $1.24 billion. During the same quarter in the previous year, the business posted $1.33 EPS. The firm’s revenue was up 5.0% on a year-over-year basis. As a group, research analysts expect that Amdocs Limited will post 5.87 EPS for the current fiscal year.

Amdocs Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Stockholders of record on Friday, March 29th will be issued a $0.479 dividend. This is a boost from Amdocs’s previous quarterly dividend of $0.44. The ex-dividend date is Wednesday, March 27th. This represents a $1.92 annualized dividend and a dividend yield of 2.24%. Amdocs’s dividend payout ratio is presently 41.11%.

Analyst Upgrades and Downgrades

DOX has been the topic of a number of research analyst reports. Citigroup boosted their price target on shares of Amdocs from $96.00 to $104.00 and gave the company a “buy” rating in a research note on Wednesday, January 17th. StockNews.com downgraded shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Friday, March 15th. Finally, Barclays upped their target price on shares of Amdocs from $105.00 to $115.00 and gave the stock an “overweight” rating in a research note on Thursday, February 8th. Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, Amdocs presently has an average rating of “Buy” and a consensus target price of $108.60.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.